Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 508
of 26Next
1:

A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study.

Hedden SL, Woolson RF, Malcolm RJ.

Subst Abuse Treat Prev Policy. 2008 Jun 3;3:13.

PMID: 18522752 [PubMed - indexed for MEDLINE]

2:

The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.

Hedden SL, Woolson RF, Carter RE, Palesch Y, Upadhyaya HP, Malcolm RJ.

J Subst Abuse Treat. 2008 Nov 12. [Epub ahead of print]

PMID: 19008067 [PubMed - as supplied by publisher]

3:

A simulation study of estimators for rates of change in longitudinal studies with attrition.

Wang-Clow F, Lange M, Laird NM, Ware JH.

Stat Med. 1995 Feb 15;14(3):283-97.

PMID: 7724914 [PubMed - indexed for MEDLINE]

4:

The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.

Mallinckrodt CH, Kaiser CJ, Watkin JG, Molenberghs G, Carroll RJ.

Clin Trials. 2004;1(6):477-89.

PMID: 16279288 [PubMed - indexed for MEDLINE]

5:

Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.

Yang X, Shoptaw S.

Drug Alcohol Depend. 2005 Mar 7;77(3):213-25.

PMID: 15734221 [PubMed - indexed for MEDLINE]

6:

Clinical trial optimization: Monte Carlo simulation Markov model for planning clinical trials recruitment.

Abbas I, Rovira J, Casanovas J.

Contemp Clin Trials. 2007 May;28(3):220-31. Epub 2006 Aug 10.

PMID: 16979387 [PubMed - indexed for MEDLINE]

7:

A reviewer's perspective on multiple endpoint issues in clinical trials.

Huque MF, Sankoh AJ.

J Biopharm Stat. 1997 Nov;7(4):545-64. Review.

PMID: 9358328 [PubMed - indexed for MEDLINE]

8:

Handling missing quality of life data in HIV clinical trials: what is practical?

Fairclough DL, Thijs H, Huang IC, Finnern HW, Wu AW.

Qual Life Res. 2008 Feb;17(1):61-73. Epub 2007 Dec 11.

PMID: 18071926 [PubMed - indexed for MEDLINE]

9:

Testing for robustness in Monte Carlo studies.

Serlin RC.

Psychol Methods. 2000 Jun;5(2):230-40.

PMID: 10937332 [PubMed - indexed for MEDLINE]

10:

Identifying the types of missingness in quality of life data from clinical trials.

Curran D, Bacchi M, Schmitz SF, Molenberghs G, Sylvester RJ.

Stat Med. 1998 Mar 15-Apr 15;17(5-7):739-56. Review.

PMID: 9549820 [PubMed - indexed for MEDLINE]

11:

Test for interaction between treatment and stratum with ordinal responses.

Uesaka H.

Biometrics. 1993 Mar;49(1):123-9.

PMID: 8513097 [PubMed - indexed for MEDLINE]

12:

Exemplary data: sample size and power in the design of event-time clinical trials.

Goldman AI, Hillman DW.

Control Clin Trials. 1992 Aug;13(4):256-71.

PMID: 1330432 [PubMed - indexed for MEDLINE]

13:

Power analyses for longitudinal study designs with missing data.

Tu XM, Zhang J, Kowalski J, Shults J, Feng C, Sun W, Tang W.

Stat Med. 2007 Jul 10;26(15):2958-81.

PMID: 17154250 [PubMed - indexed for MEDLINE]

14:

Imputation methods for missing outcome data in meta-analysis of clinical trials.

Higgins JP, White IR, Wood AM.

Clin Trials. 2008;5(3):225-39.

PMID: 18559412 [PubMed - indexed for MEDLINE]

15:

Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases.

Unnebrink K, Windeler J.

Stat Med. 2001 Dec 30;20(24):3931-46.

PMID: 11782044 [PubMed - indexed for MEDLINE]

16:

Design and analysis of group sequential logrank tests in maximum duration versus information trials.

Kim K, Boucher H, Tsiatis AA.

Biometrics. 1995 Sep;51(3):988-1000.

PMID: 7548714 [PubMed - indexed for MEDLINE]

17:

Weibull prediction of event times in clinical trials.

Ying GS, Heitjan DF.

Pharm Stat. 2008 Apr-Jun;7(2):107-20.

PMID: 17377932 [PubMed - indexed for MEDLINE]

18:

Practical usage of O'Brien's OLS and GLS statistics in clinical trials.

Dallow NS, Leonov SL, Roger JH.

Pharm Stat. 2008 Jan-Mar;7(1):53-68.

PMID: 17390306 [PubMed - indexed for MEDLINE]

19:

Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.

Sébille V, Hardouin JB, Mesbah M.

Stat Med. 2007 Nov 30;26(27):4889-904.

PMID: 17576119 [PubMed - indexed for MEDLINE]

20:

Advances in statistical methods for substance abuse prevention research.

MacKinnon DP, Lockwood CM.

Prev Sci. 2003 Sep;4(3):155-71. Review.

PMID: 12940467 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 508
of 26Next